MHRA Drug Safety Update November 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 4 November 2022) has been published and includes articles on:

• Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management
• Consultation with healthcare professionals: please complete our consultation to help influence how we communicate with you
• COVID-19 vaccines and medicines: updates for November 2022
• Letters and medicine recalls sent to healthcare professionals in October 2022

To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.